Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2015
Total Assets: $64.7M
Liabilities Breakdown FY2015
Total Liabilities: $54.7M
Asset Breakdown
Total Assets: $64.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $8.3M | 12.8% |
| Accounts Receivable | $2.8M | 4.3% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.5M | 2.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $43.5M | 67.2% |
| Other Assets | $8.7M | 13.4% |
Liabilities Breakdown
Total Liabilities: $54.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.6M | 2.9% |
| Long-Term Debt | $7.2M | 13.2% |
| Other Liabilities | $45.9M | 83.9% |